Association of Hormonal Contraceptive Use With Reduced Levels of Depressive Symptoms: A National Study of Sexually Active Women in the United States
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
An estimated 80% of sexually active young women in the United States use hormonal contraceptives during their reproductive years. Associations between hormonal contraceptive use and mood disturbances remain understudied, despite the hypothesis that estrogen and progesterone play a role in mood problems. In this study, we used data from 6,654 sexually active nonpregnant women across 4 waves of the National Longitudinal Study of Adolescent Health (1994-2008), focusing on women aged 25-34 years. Women were asked about hormonal contraceptive use in the context of a current sexual partnership; thus, contraceptive users were compared with other sexually active women who were using either nonhormonal contraception or no contraception. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale. At ages 25-34 years, hormonal contraceptive users had lower mean levels of concurrent depressive symptoms (β = -1.04, 95% confidence interval: -1.73, -0.35) and were less likely to report a past-year suicide attempt (odds ratio = 0.37, 95% confidence interval: 0.14, 0.95) than women using low-efficacy contraception or no contraception, in models adjusted for propensity scores for hormonal contraceptive use. Longitudinal analyses indicated that associations between hormonal contraception and depressive symptoms were stable. Hormonal contraception may reduce levels of depressive symptoms among young women. Systematic investigation of exogenous hormones as a potential preventive factor in psychiatric epidemiology is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403 · cited 8×
“Depression score in waves 1 and 2 was measured with the 20-item CES-D (possible range of scores, 0–60).”
InfluentialNock, M. K., Borges, G., Bromet, E. J., Cha, C. B., Kessler, R. C., & Lee, S. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn002 · Cited by 2,897
Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00006 · Cited by 1,890 · cited 1×
“(65) documented that free salivary cortisol responses to a laboratorygenerated psychosocial stressor were lowest among hormonal contraceptive users as compared with men as well as women in the luteal and follicular phases, while total cortisol responses did not differ between groups, suggesting a higher level of corti…”
Global burden of depressive disorders in the year 2000
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. L. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.5.386 · Cited by 1,735
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1097 · Cited by 1,645
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001) · Contraception · doi:10.1016/s0010-7824(01)00218-9 · Cited by 347
Contraceptive hormone use and cardiovascular disease
Shufelt, C. L., & Bairey Merz, C. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.042 · Cited by 287 · cited 1×
“In addition to providing effective pregnancy prevention, hormonal contraception offers many health benefits (2–4), though its use remains a risk factor for venous thromboembolism and other vascular disease outcomes (5).”
To what extent do oral contraceptives influence mood and affect?
Oinonen, K. A., & Mazmanian, D. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00356-1 · Cited by 268
The state of hormonal contraception today: established and emerging noncontraceptive health benefits
Maguire, K., & Westhoff, C. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.056 · Cited by 124
Self-citationRobinson, S. A., Dowell, M., Pedulla, D., & McCauley, L. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.013 · Cited by 68
Using changes in binding globulins to assess oral contraceptive compliance
Westhoff, C. L., Petrie, K. A., & Cremers, S. (2013) · Contraception · doi:10.1016/j.contraception.2012.06.003 · Cited by 22
Self-citation
Cited by
Association of Hormonal Contraception With Depression
Skovlund, C. W., Mørch, L. S., Kessing, L. V., & Lidegaard, Ø. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2387 · Cited by 675
Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research
Robakis, T., Williams, K. E., Nutkiewicz, L., & Rasgon, N. L. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1034-z · Cited by 103
Gobinath, A. R., Choleris, E., & Galea, L. A. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23872 · Cited by 87
Variation in serum biomarkers with sex and female hormonal status: implications for clinical tests
Ramsey, J. M., Cooper, J. D., Penninx, B. W. J. H., & Bahn, S. (2016) · Scientific Reports · doi:10.1038/srep26947 · Cited by 45
Adverse psychiatric effects of non-psychotropic medications
Gupta, A., & Chadda, R. K. (2016) · BJPsych Advances · doi:10.1192/apt.bp.115.015735 · Cited by 16
Metadata
- Authors
- Keyes, K. M., Cheslack-Postava, K., Westhoff, C., Heim, C. M., Haloossim, M., Walsh, K., & Koenen, K.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-09-15
- Volume
- 178
- Issue
- 9
- Pages
- 1378-1388
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2168522614
- Cited by
- 162
- References
- 12
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.